AVIXIM-CV

Description

• Active Ingredients:
  • Cefixime Trihydrate IP 200 mg: A third-generation cephalosporin antibiotic.
  • Potassium Clavulanate IP 125 mg: A beta-lactamase inhibitor that enhances the efficacy of cefixime.
• Indications:
  • Respiratory tract infections (e.g., bronchitis, pneumonia)
  • Urinary tract infections (e.g., cystitis, pyelonephritis)
  • Skin and soft tissue infections
  • Otitis media (middle ear infections)
  • Pharyngitis and tonsillitis
  • Gonorrhea (uncomplicated)
• Mechanism of Action:
  • Cefixime: Inhibits bacterial cell wall synthesis, leading to cell lysis and death.
  • Potassium Clavulanate: Inhibits beta-lactamase enzymes produced by resistant bacteria, preventing the degradation of cefixime.
• Benefits:
  • Broad-spectrum antibiotic coverage effective against beta-lactamase-producing bacteria.
  • Enhanced efficacy in treating resistant bacterial infections.
  • Provides rapid relief from infection symptoms.
• Precautions: Not recommended for individuals with a known hypersensitivity to cephalosporin antibiotics or beta-lactamase inhibitors. Use with caution in patients with a history of gastrointestinal diseases, particularly colitis, and those with renal impairment.